Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01123239 · ClinicalTrials.gov registry record · NA
Understanding and Improving Diabetes Care for Ethnic Minorities
A NA study of Diabetes Mellitus, Type 2, sponsored by University of California, Irvine.
- Completed
- Registry status
- NA
- Development phase
- 540
- Enrollment target
- 3
- Study locations
NCT01123239: Completed NA study of Diabetes Mellitus, Type 2, sponsored by University of California, Irvine.
NCT01123239 is a NA study of Diabetes Mellitus, Type 2 that has completed, run by University of California, Irvine. The registered enrollment target is 540 participants, below the 4,484-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (88% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01123239, a NA study of Diabetes Mellitus, Type 2, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- NA
- Development phase
- 540 participants
- Enrollment target
- 3
- Study locations
Study Summary
In this study, we are testing the effectiveness of an intervention known as "Coached Care" to improve health outcomes and quality of care of patients being treated for type 2 diabetes, particularly patients in underserved populations. The intervention involves training members of minority communities who have diabetes to be "coaches", teaching minority patients the skills needed to participate effectively in care during office visits, as they present for those visits. Coaches follow patients for 9 routine consecutive visits, reinforcing participation skills before and between their routine office visits.
Primary Outcome
A laboratory measure of blood sugar control
Conditions Studied
Interventions
- BEHAVIORAL Coached Care
- BEHAVIORAL Standard Diabetes Education
Study Locations (3)
California
- Mary and Dick Allen Diabetes Center at Hoag Hospital - Newport Beach
- University of California Irvine Medical Center - Orange
- Westminster Medical Center - Westminster
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 540 participants |
| Start Date | 2006-01 |
| Est. Completion | 2013-03 |
| Phase | NA |
What the finished NCT01123239 record still lists
NCT01123239 is an interventional study that assigns participants to a tested intervention. The registered 540 participants enrollment target is mid-sized for trials with a published cap, below the 4,484-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which Coached Care is the first listed.
NCT01123239 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01123239 about?
NCT01123239 is a clinical study titled "Understanding and Improving Diabetes Care for Ethnic Minorities". In this study, we are testing the effectiveness of an intervention known as "Coached Care" to improve health outcomes and quality of care of patients being treated for type 2 diabetes, particularly patients in underserved populations. The intervention involves training members of minority communitie...
What is the current status of trial NCT01123239?
This trial is currently completed. It is a NA study. The enrollment target is 540 participants. The study started on 2006-01. Estimated completion is 2013-03.
What conditions does trial NCT01123239 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2.
What interventions are being tested in trial NCT01123239?
The interventions under investigation include: Coached Care (BEHAVIORAL), Standard Diabetes Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT01123239?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01123239 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01123239's enrollment target sits among peer trials
540 71st of 348 higher than 278 of 348 other Diabetes Mellitus, Type 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Phenotyping Genetic Risk for Type 2 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04557462 · 540 participants · Phase 3
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- NCT04956640 · 540 participants · Phase 1
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
- NCT05429892 · 540 participants · NA
FRESH Delivers: An Innovative Approach to Reducing Tobacco Use Among Rural Smokers
- NCT05549297 · 540 participants · Phase 3
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia